Announce Date | 08/05/2025 |
EPS Normalized Actual | $2.95 (Beat by $0.02) |
EPS GAAP Actual | $2.95 (Beat by $0.02) |
Revenue Actual | $7.028B |
Revenue Surprise | Beat by $7028M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.94044 |
EPS GAAP Estimate | $2.94044 |
Revenue Estimate | $6.905401501B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 20.2738 | 18.05 | 19.89447 | 20.77533 | 3 |
Dec 2028 | 17.3933 | 21.04 | 17.17784 | 17.59605 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.51 | -0.28829 | 7.028B | 9.65% | 315.63M |
FQ1 2025 (Mar 2025) | 2.45793 | 2.45793 | 6.377B | 6.81% | 6377M |
FQ4 2024 (Dec 2024) | 2.46 | 2.46 | 6.24B | 4.38% | 6240M |
FQ3 2024 (Sep 2024) | 2.54 | 2.54 | 6.345B | 7.33% | 6345M |
FQ2 2024 (Jun 2024) | 2.49 | 2.49 | 6.35B | 7.62% | 6350M |
FQ1 2024 (Mar 2024) | 2.05 | 2.05 | 5.943B | 7.74% | 5943M |
FQ4 2023 (Dec 2023) | 2.37 | 2.37 | 5.967B | 9.77% | 5967M |
FQ3 2023 (Sep 2023) | 2.23 | 2.23 | 5.88B | 9.64% | 5880M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.94044
Consensus Revenue Estimates
6.905401501B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 4.1491 | -- | 4.04718 | 4.20616 | 6 |
FQ3 2027 (Sep 2027) | 3.82866 | -- | 3.76946 | 3.91758 | 8 |
FQ2 2027 (Jun 2027) | 3.72573 | -- | 3.66813 | 3.81226 | 5 |
FQ1 2027 (Mar 2027) | 3.31427 | -- | 3.27037 | 3.36843 | 9 |
FQ4 2026 (Oct 2026) | 3.61399 | -- | 3.56122 | 3.68372 | 4 |
FQ3 2026 (Jul 2026) | 3.37719 | -- | 3.32788 | 3.44235 | 4 |
FQ2 2026 (Jun 2026) | 3.29071 | 23.72 | 3.23295 | 3.34478 | 3 |
FQ1 2026 (Mar 2026) | 2.98702 | 17.71 | 2.93459 | 3.0361 | 6 |
FQ4 2025 (Oct 2025) | 3.09532 | 20.53 | 3.05012 | 3.15504 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 8.6B | -- | 8.44B | 8.69B | 6 |
FQ3 2027 (Sep 2027) | 7.87B | -- | 7.77B | 8.01B | 5 |
FQ2 2027 (Jun 2027) | 7.77B | -- | 7.68B | 7.91B | 5 |
FQ1 2027 (Mar 2027) | 7.27B | -- | 7.2B | 7.36B | 6 |
FQ4 2026 (Oct 2026) | 7.5B | -- | 7.42B | 7.61B | 4 |
FQ3 2026 (Jul 2026) | 7.45B | -- | 7.36B | 7.56B | 4 |
FQ2 2026 (Jun 2026) | 7.29B | 3.61 | 7.19B | 7.38B | 4 |
FQ1 2026 (Mar 2026) | 6.86B | 7.1 | 6.77B | 6.95B | 7 |
FQ4 2025 (Oct 2025) | 6.94B | 10.04 | 6.86B | 7.04B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.79829 | 2.51 | -0.28829 | -11.49% |
FQ1 2025 (Mar 2025) | 2.45793 | 2.45793 | 100% | |
FQ4 2024 (Dec 2024) | 2.46 | 2.46 | 100% | |
FQ3 2024 (Sep 2024) | 2.54 | 2.54 | 100% | |
FQ2 2024 (Jun 2024) | 2.49 | 2.49 | 100% | |
FQ1 2024 (Mar 2024) | 2.05 | 2.05 | 100% | |
FQ4 2023 (Dec 2023) | 2.37 | 2.37 | 100% | |
FQ3 2023 (Sep 2023) | 2.23 | 2.23 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $6.71B | $7.03B | $315.63M | 4.49% |
FQ1 2025 (Mar 2025) | $0B | $6.38B | $6377M | 100% |
FQ4 2024 (Dec 2024) | $0B | $6.24B | $6240M | 100% |
FQ3 2024 (Sep 2024) | $0B | $6.35B | $6345M | 100% |
FQ2 2024 (Jun 2024) | $0B | $6.35B | $6350M | 100% |
FQ1 2024 (Mar 2024) | $0B | $5.94B | $5943M | 100% |
FQ4 2023 (Dec 2023) | $0B | $5.97B | $5967M | 100% |
FQ3 2023 (Sep 2023) | $0B | $5.88B | $5880M | 100% |